MedPath

A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Not Applicable
Completed
Conditions
Cytomegalovirus Retinitis
HIV Infections
Registration Number
NCT00002330
Lead Sponsor
Roche Global Development
Brief Summary

To compare the time to progression of Cytomegalovirus (CMV) retinitis among each of three doses of oral ganciclovir, as well as to intravenous therapy, when given as maintenance for 26 weeks. To compare the safety and tolerance among oral doses of ganciclovir at the study doses, as well as to intravenous therapy, when administered as maintenance for 26 weeks.

Detailed Description

Patients who have received anti-CMV therapy with intravenous ganciclovir for at least 4 weeks that resulted in stable retinitis are randomized to receive one of three doses of oral ganciclovir or intravenous ganciclovir for 26 weeks of maintenance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (36)

Univ of Alabama at Birmingham / AIDS Outpatient Clinic

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

McDowell Clinic

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Dr Ken Fisher

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Univ of Arizona / Health Science Ctr

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

East Bay AIDS Ctr

πŸ‡ΊπŸ‡Έ

Berkeley, California, United States

AIDS Clinical Research Ctr / UCLA Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

UCSD Med Ctr / Pediatrics

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

Davies Med Ctr

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Mount Zion Med Ctr / UCSF

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

San Francisco Veterans Administration Med Ctr

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Scroll for more (26 remaining)
Univ of Alabama at Birmingham / AIDS Outpatient Clinic
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.